U.S. Food and Drug Administration issued two final guidances, “Investigator Responsibilities—Safety Reporting for Investigational Drugs and Devices” and “Sponsor Responsibilities—Safety Reporting Requirements and Safety Assessment for IND and Bioavailability/Bioequivalence Studies.”